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Summary
 
The thymic medulla plays a key role in negative selection (self-tolerance induction) and con-
tains differentiated T cells en route to the extrathymic environment. However, being relatively
mature, medullary T cells are thought to be beyond the stage of tolerance induction. This para-
dox is resolved by the finding that medullary T cells (CD4
 
1
 
8
 
2
 
 thymocytes) comprise two dis-
tinct subsets. Medullary thymocytes expressing a fully mature (HSA
 
lo
 
) phenotype are strongly
resistant to tolerance induction, whereas cells with a semimature (HSA
 
hi
 
) phenotype are toler-
ance susceptible. These findings suggest that the differentiated T cells reaching the medulla
from the cortex remain sensitive to tolerance induction for a brief period before acquiring a
fully mature tolerance-resistant phenotype. The semimature subset of medullary T cells displays
unique requirements for tolerance induction; depending upon the conditions used, tolerizing
these cells can involve either a Fas (CD95)-dependent or a Fas-independent pathway.
 
D
 
ifferentiation of CD4
 
1
 
8
 
1
 
 (double-positive, DP)
 
1
 
 thy-
mocytes into mature single-positive (SP) CD4
 
1
 
8
 
2
 
 and
CD4
 
2
 
8
 
1
 
 cells involves positive and negative selection and
is directed to an array of self-peptides bound to MHC mol-
ecules (1–7). Negative selection deletes T cells with high
affinity for self-peptides via apoptosis, thus ensuring self-
tolerance, and is presumed to reflect strong signaling via
TCR recognition of peptide–MHC complexes on APC. In
addition to TCR ligation, negative selection appears to re-
quire second signals delivered through contact with co-
stimulatory molecules on APC (3–5, 8–10). Although APC
express a variety of costimulatory molecules, including B7-1,
B7-2, ICAM-1, and HSA (11–13), which of these mole-
cules are required for negative selection is unclear (3–5).
Unlike the cortex, the thymic medulla is packed with
bone marrow (BM)–derived APC and is permeable to cir-
culating self-antigens entering from the bloodstream (14).
Thus, the medulla is a likely site for negative selection. In
favor of this idea, negative selection to endogenous super-
antigens and to serum proteins, e.g., C5, takes place at a
relatively late stage of thymocyte differentiation and is asso-
ciated with the appearance of apoptotic cells in the medulla
(15–19). However, a key problem with the notion that
negative selection occurs in the medulla is that most of the
T cells in the medulla are relatively mature (6) and thus are
presumably beyond the stage of being tolerance susceptible.
One explanation for this paradox is that, after positive se-
lection in the cortex, maturing SP thymocytes remain tol-
erance susceptible for a brief period after reaching the me-
dulla.
Maturation of SP cells is associated with downregulation of
heat-stable antigen (HSA) (3, 20, 21) and upregulation of
Qa-2 molecules (22, 23). In contrast with fully mature HSA
 
lo
 
Qa-2
 
hi
 
 thymocytes, partly immature HSA
 
hi
 
 Qa-2
 
lo
 
 SP thy-
mocytes are functionally incompetent in the absence of ex-
ogenous lymphokines (23–25). Whether these latter cells
are tolerance susceptible is unclear, although a subset of
HSA
 
interm
 
 CD4
 
1
 
8
 
lo
 
 thymocytes is reported to undergo apop-
tosis in response to TCR ligation in vitro (25). In this paper,
we compare purified subsets of CD4
 
1
 
8
 
1
 
, HSA
 
hi
 
 CD4
 
1
 
8
 
2
 
,
and HSA
 
lo
 
 CD4
 
1
 
8
 
2
 
 thymocytes for their relative sensitivity
to TCR-mediated apoptosis in vitro and in vivo. The re-
sults suggest that immature CD4
 
1
 
8
 
1
 
 and semimature
HSA
 
hi
 
 CD4
 
1
 
8
 
2
 
 thymocytes are both susceptible to nega-
tive selection. However, the conditions required for toler-
izing these two subsets are distinctly different.
 
Materials and Methods
 
Mice.
 
Adult C57BL/6 (B6) and B6 
 
lpr
 
/
 
lpr
 
 mice aged 8–12
wk were obtained from The Scripps Research Institute breeding
facility.
 
Antibodies.
 
Antibodies specific for the following markers
were previously described (26): CD3 (C363.29B, rat IgG), CD4
(RL172, rat IgM), CD8 (3.163.8, rat IgM), CD25 (7D4, rat
IgM), HSA (J11D, rat IgM), and class II (M5/114, rat IgG). Puri-
fied mAbs from ascites specific for TCR-
 
b
 
 (H57-597, hamster
IgG) (27) and CD28 (37.51, hamster IgG) (28) were used for
 
1
 
Abbreviations used in this paper:
 
 AICD, activation-induced cell death; BM,
bone marrow; C, constant; DP, double positive; FasL, Fas ligand; HSA, heat-
stable antigen; PI, propidium iodide; SP, single positive; TUNEL, terminal
deoxynucleotidyl transferase–mediated dUTP-biotin nick end labeling.
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stimulation of cells. The following mAbs were purchased from
GIBCO BRL (Gaithersburg, MD): FITC–anti-CD4 (H129.19, rat
IgG), FITC–anti-CD25 (3C7, rat IgG) and Red613–anti-CD8
(53-6.7, rat IgG). FITC-conjugated mAbs specific for CD69
(H1.2F3, hamster IgG) and Qa-2 (1-1-2, mouse IgG) were pur-
chased from PharMingen (San Diego, CA). PE-conjugated anti-
CD4 mAb (GK1.5, rat IgG) was purchased from Collaborative
Biomedical Products (Bedford, MA).
 
Cell Purification.
 
Purification of TCR
 
lo
 
 CD4
 
1
 
8
 
1
 
 thymocytes
was performed as described previously (29). For purification of
HSA
 
hi
 
 CD4
 
1
 
8
 
2
 
 cells, thymocytes were treated with mAbs spe-
cific for CD8 (3.168.8) and CD25 (7D4) plus guinea pig comple-
ment (C) for 45 min at 37
 
8
 
C, positively panned with anti-CD4
(RL172) mAb, then positively panned with anti-HSA (J11d)
mAb; panning was performed at 4
 
8
 
C. HSA
 
lo 
 
CD4
 
1
 
8
 
2
 
 cells were
purified by treating thymocytes with mAbs to HSA, CD8, and
CD25 plus guinea pig C at 37
 
8
 
C followed by positive panning
with anti-CD4 mAb. CD4
 
1
 
 LN T cells were purified by treating
pooled LN cells with mAbs specific for HSA, CD8, and class II plus
guinea pig C, followed by positive panning with anti-CD4 mAb.
 
In Vivo Treatment for Deletion of Immature Thymocytes.
 
B6 mice
aged 8 wk were injected intraperitoneally with 100 
 
m
 
g/mouse of
anti-TCR mAb (H57-597) or 1 mg/mouse of cortisone acetate
(Sigma, St. Louis, MO). At 20 or 48 h after injection, the mice
were sacrificed and cell surface markers of thymocytes were ana-
lyzed.
 
Culture Conditions.
 
Whole thymocytes (5 
 
3
 
 10
 
5
 
) or purified
cells (2–3 
 
3
 
 10
 
5
 
) from B6 or B6 
 
lpr
 
/
 
lpr
 
 mice were cultured in 0.2 ml
of RPMI medium supplemented with 5 
 
3
 
 10
 
2
 
5
 
 M 2-mercapto-
ethanol, 
 
L
 
-glutamine and 10% FCS in 96-well tissue culture
plates coated with anti-TCR (H57-597) 
 
6
 
 anti-CD28 (37.51)
mAbs or medium alone for 20 h. After harvesting, cells were
stained and analyzed on a FACScan
 
Ò
 
 (Becton Dickinson, San
Jose, CA).
 
Cell Surface and TUNEL Staining.
 
For the in vivo studies, thy-
mocytes were incubated with FITC-conjugated mAbs to HSA
(J11d), Qa-2 (1-1-2), or CD69 (H1.2F3), followed by PE-conju-
gated anti-CD4 (GK1.5) and Red613-conjugated anti-CD8 (53-
6.7) mAbs; dead cells were gated out by propidium iodide (PI)
staining. For the in vitro studies, purified cells were stained with
FITC-conjugated anti-CD69 or anti-CD25 (3C7) mAbs, and
then TUNEL stained after cell fixation. TUNEL staining was de-
scribed previously (29).
 
Results
 
Elimination of Thymocyte Subsets In Vivo.
 
Acute negative
selection of thymocytes can be induced by injecting mice
with anti-TCR (or anti-CD3) mAb i.p. (30); in this model,
costimulation is presumably provided by bystander APC
(31, 32). As shown in Fig. 1 
 
A
 
, injecting mice with anti-
TCR mAb ablated immature CD4
 
1
 
8
 
1
 
 thymocytes by 48 h
after injection and caused a reciprocal increase in SP
CD4
 
1
 
8
 
2
 
 and CD4
 
2
 
8
 
1
 
 cells. However, gating on CD4
 
1
 
8
 
2
 
cells at 48 h revealed that this population consisted almost
entirely of fully mature HSA
 
lo
 
 Qa-2
 
hi
 
 CD69
 
lo
 
 cells; the ma-
jor subset of semimature HSA
 
hi
 
 Qa-2
 
lo
 
 CD69
 
hi
 
 cells was
virtually undetectable. These semimature T cells were prom-
inent in normal (PBS-injected) mice and were not depleted
after cortisone treatment. The data in Fig. 1 
 
A
 
 refer to adult
8-wk-old mice. Essentially similar findings applied when
anti-TCR mAb was injected into neonatal (1-wk-old) mice
(data not shown). However, in this situation, the elimina-
tion of thymocytes was prominent for semimature HSA
 
hi
 
CD4
 
1
 
8
 
2
 
 cells but not for CD4
 
1
 
8
 
1
 
 cells, suggesting that
the destruction of CD4
 
1
 
8
 
1
 
 cells in adult mice (Fig. 1 
 
A
 
)
was probably largely mediated by cytokines and/or in-
creased steroid levels released via anti-TCR stimulation of
mature postthymic T cells.
 
In Vitro Studies.
 
Negative selection can be reproduced
in vitro by culturing dissociated thymocytes with a combi-
nation of anti-TCR and anti-CD28 mAbs in cross-linked
form (8); ligation of CD28 (the T cell coreceptor for B7-1
and B7-2 on APC) (11, 12) provides costimulation. As
shown in Fig. 1 
 
B
 
, culturing unseparated thymocytes in
vitro for 20 h on plates coated with a mixture of anti-TCR
and anti-CD28 mAbs caused substantial, though incom-
plete, depletion of HSA
 
hi
 
 CD4
 
1
 
8
 
2
 
 cells. These in vitro
findings correlated closely with the partial depletion of
HSA
 
hi
 
 CD4
 
1
 
8
 
2
 
 cells found at 20 h after anti-TCR injec-
tion in vivo (Fig. 1 
 
A
 
).
To extend these findings, purified subsets of thymocytes
were tested for their sensitivity to negative selection (apop-
tosis) mediated by cross-linked anti-TCR plus anti-CD28
mAbs in vitro; exposure to cross-linked anti-TCR mAb
alone was used as a control. Apoptosis was measured by
TUNEL staining after overnight culture. Fig. 2 shows the
purity of the cells tested (
 
A
 
, 
 
left
 
), TUNEL staining of the
cultured cells (
 
A
 
, 
 
right
 
), and the expression of two acti-
vation markers, CD69 and CD25 (IL-2R), on viable
(TUNEL
 
2
 
) cells (
 
B
 
); cells were cultured on plates coated
with anti-CD28 (20 
 
m
 
g/ml) and/or anti-TCR (10 
 
m
 
g/ml)
mAbs. Fig. 3 
 
A
 
 shows the effects of culturing the cells with
decreasing concentrations of anti-TCR mAb 
 
6
 
 a fixed
concentration of anti-CD28 mAb (20 
 
m
 
g/ml); background
levels of apoptosis found with cells cultured in medium
alone have been subtracted, and the data are shown as
change in apoptosis. The data in Figs. 2 and 3 
 
A make
three points (see Fig. 2, legend).
First, confirming the findings of others (8), inducing
apoptosis of immature CD4181 thymocytes in vitro required
combined TCR–CD28 ligation; ligation of TCR alone
caused strong upregulation of CD69 but not CD25 (indic-
ative of partial activation), but failed to cause apoptosis. Neg-
ative selection of immature CD4181 cells thus was crucially
dependent upon costimulation.
Second, diametrically opposite findings applied to fully
mature thymocytes, i.e., to HSAlo CD4182 cells, and also
to mature LN CD4182 cells. Surprisingly, these two popu-
lations of mature T cells were susceptible to apoptosis me-
diated by TCR ligation alone. However, combined TCR–
CD28 ligation failed to cause apoptosis and, instead, led to
T cell activation associated with CD69 and CD25 upregu-
lation, an increase in cell size (increased forward scatter
[FSC]), and a reduction in apoptosis relative to cells cul-
tured alone.
Third, the semimature subset of HSAhi CD4182 cells
behaved as an intermediate population. These cells were
sensitive to apoptosis mediated by TCR ligation alone, and265 Kishimoto and Sprent
thus resembled mature HSAlo CD4182 cells. However, at low
doses of anti-TCR mAb (Fig. 3 A), TCR-induced apoptosis
of HSAhi CD4182 cells was considerably enhanced by CD28
coligation. The properties of HSAhi CD4182 cells thus were
midway between immature CD4181 cells and mature HSAlo
CD4182 cells; this also applied to the extent of CD69 and
CD25 upregulation after combined TCR–CD28 ligation.
In terms of their sensitivity to TCR–CD28 ligation,
HSAhi CD4182 cells differed from immature CD4181 cells
in two respects. First, titrating the dose of anti-TCR mAb
(with a fixed amount of anti-CD28 mAb) revealed that
HSAhi CD4182 cells were appreciably less sensitive to
TCR–CD28-mediated apoptosis than CD4181 cells (Fig.
3 B). Thus, the dose of anti-TCR mAb required to induce
apoptosis was about fivefold higher for CD4182 cells than
for CD4181 cells; this difference was surprising because the
TCR density on HSAhi CD4182 cells was 5- to 10-fold
higher than on CD4181 cells (data not shown). Second, as
discussed below, these two populations differed in their
sensitivity to Fas (CD95)-mediated apoptosis.
Role of Fas. It is well accepted that activation-induced
cell death of mature postthymic T cells is largely Fas-medi-
ated and reflects contact with Fas ligand (FasL) (33–38).
However, to date there is no clear evidence that Fas plays a
role in negative selection in the thymus (39, 40). In agree-
ment with this view, TCR–CD28-mediated apoptosis of
Figure 1. Negative selection
of HSAhi CD4182 thymocytes in
vivo and in vitro. (A) Cell sur-
face expression of HSA, Qa-2,
and CD69 on CD4182 thy-
mocytes after injection of anti-
TCR mAb, cortisone acetate, or
PBS; total numbers of thy-
mocytes recovered are shown at
the left. (B) Cell surface expres-
sion of HSA on CD4182 thy-
mocytes recovered after cultur-
ing unseparated thymocytes for
20 h on plates coated with a
mixture of anti-TCR mAb (10
mg/ml) and anti-CD28 mAb (20
mg/ml) or on uncoated plates
(medium alone). Surface stain-
ing on viable (PI2) cells is
shown; the downregulation of
CD4 and CD8 on CD4181 cells
is typical of cells undergoing
early TCR-mediated apoptosis
(29); yields of total viable (PI2)
cells in the cultures were 85% for
cells cultured in medium alone
and 52% for cells cultured with
anti-TCR plus anti-CD28 mAbs.266 Negative Selection of CD4182 Thymocytes
immature CD4181 thymocytes could not be blocked with
a soluble Fas fusion protein (Fas–Ig) (41) and was unimpaired
when CD4181 thymocytes were prepared from Fas-deficient
B6 lpr/lpr mice (Fig. 4 A). Interestingly, however, TCR–
CD28-mediated apoptosis of semimature HSAhi CD4182
cells was abolished by Fas–Ig and was almost undetectable
with cells from B6 lpr/lpr mice. These findings also applied
to ligation with TCR alone (Fig. 4 A).
Because negative selection in vivo is not thought to be
Fas dependent, the dominant role of Fas in TCR–CD28-
mediated apoptosis of HSAhi CD4182 cells in vitro was sur-
prising. However, titration experiments showed that the
Fas dependency of these cells to TCR–CD28-mediated apop-
tosis only applied with high doses of anti-TCR mAb, e.g.,
10–20 mg/ml (Fig. 4, A and B, middle). At this concentra-
tion, TCR–CD28-mediated apoptosis of HSAhi CD4182
Figure 2. Apoptosis of thy-
mocyte subsets and LN T cells
induced by stimulation with
anti-TCR mAb or anti-TCR
plus anti-CD28 mAbs in vitro.
Purified populations of CD4181,
HSAhi CD4182, and HSAlo
CD4182 thymocytes and
CD4182 LN cells were cultured
for 20 h in vitro on plates coated
with anti-TCR mAb alone
(H57, 10 mg/ml) or with a mix-
ture of anti-TCR (10 mg/ml)
and anti-CD28 (20 mg/ml)
mAbs. (A) The purity of the sub-
sets before culture (left) and the
extent of apoptosis determined
by TUNEL staining after culture
(right) are shown; for TUNEL
staining, the forward scatter
(FSC) profile shows the relative
size of the cells. (B) Shows sur-
face expression of CD69 and
CD25 (IL-2R) on viable
(TUNEL2) cells after culture. To
exclude the possibility that CD4
ligation during the panning pro-
cedure affected the results (50),
parallel experiments were per-
formed with cells that were puri-
fied by methods that did not in-
volve CD4 ligation, e.g., by
using unmanipulated thymo-
cytes from b2m
2/2 mice as a
source of purified CD4181 cells
and CD82 IL-2R2 normal thy-
mocytes as an enriched source of
CD4182 cells. The results ob-
tained with these cells were es-
sentially identical to the data
shown in Figs. 3 and 4.267 Kishimoto and Sprent
cells was prominent with normal thymocytes but undetect-
able with B6 lpr/lpr thymocytes. Paradoxically, however,
apoptosis of HSAhi CD4182 lpr/lpr thymocytes became
clearly apparent when the dose of anti-TCR mAb was re-
duced to a low level, i.e., to 0.1 mg/ml (Fig. 4 B, middle).
In fact, at this low dose, apoptosis of lpr/lpr cells was as high
Figure 3. Concentration of anti-TCR mAb required to induce apop-
tosis of thymocyte subpopulations as measured by TUNEL staining at 20 h.
(A) Purified thymocyte subsets and LN CD4182 cells were cultured on
plates coated with various concentrations of anti-TCR mAb, i.e., 100
mg/ml to 0.1 mg/ml for stimulation with anti-TCR mAb alone, and 10
mg/ml to 1 ng/ml for stimulation with anti-TCR mAb plus a fixed
amount of 20 mg/ml of anti-CD28 mAb. (B) Comparison of the sensitiv-
ity of CD4181 and HSAhi CD4182 thymocytes to apoptosis induced by
stimulation with various concentrations of anti-TCR mAb and a fixed
amount (20 mg/ml) of anti-CD28 mAb. Background levels of apoptosis
found with cells cultured in medium alone have been subtracted, and the
data are shown as change in apoptosis. The data represent the mean from
three (A) or two (B) separate experiments.
Figure 4. Effect of Fas (CD95) on negative selection of thymocyte sub-
populations. (A) Purified cells from B6 or B6 lpr/lpr mice were cultured
for 20 h on plates coated with either anti-TCR mAb alone (20 mg/ml) or
with anti-TCR (10 mg/ml) plus anti-CD28 (20 mg/ml) mAb. Where in-
dicated, Fas–Ig fusion protein (provided by Dr. D. Lynch; 10 mg/ml) was
added to the cultures. (B) Relative sensitivity of normal B6 and B6 lpr/lpr
CD4181 and HSAhi CD4182 cells to TCR–CD28-mediated apoptosis in
vitro. Cells were cultured for 20 h on plates coated with various concen-
trations of anti-TCR mAb 6 a fixed concentration of anti-CD28 mAb as
described in Fig. 3. Apoptosis was measured by TUNEL staining. The
data represent the mean of two separate experiments.268 Negative Selection of CD4182 Thymocytes
as with normal cells. TCR–CD28-mediated apoptosis of
HSAhi CD4182 cells thus was Fas dependent at a high dose
of anti-TCR but Fas independent at a low dose. This phe-
nomenon was not seen with CD4181 cells (Fig. 4 B, left)
and did not apply when lpr/lpr HSAhi CD4182 cells were
exposed to anti-TCR mAb in the absence of anti-CD28
mAb (Fig. 4 B, right); here, apoptosis of lpr/lpr cells was un-
detectable over a wide dose range of anti-TCR mAb. The
conditions required to induce Fas-independent apoptosis of
HSAhi CD4182 cells thus were precise in two respects: (a)
the dose of anti-TCR mAb had to be low, and (b) costim-
ulation via CD28 was essential.
In contrast with semimature HSAhi CD4182 cells, apop-
tosis of fully mature HSAlo CD4182 thymocytes and CD4182
LN cells in vitro appeared to be completely Fas dependent.
Thus, apoptosis of these populations after ligation with
TCR alone was totally blocked by Fas–Ig and was not seen
with Fas-deficient lpr/lpr cells (Fig. 4 A, left). In fact, with
Fas inactivation/blockade, TCR ligation alone consider-
ably enhanced cell survival relative to cells cultured alone.
Discussion
This paper demonstrates that under defined conditions
immature (CD4181), semimature (HSAhi CD4182) and
fully mature (HSAlo CD4182) thymocytes are all suscepti-
ble to rapid induction of apoptosis after TCR ligation in
vitro. However, each population of thymocytes displayed
different requirements for apoptosis induction.
Contrary to expectation, fully mature naive HSAlo CD4182
thymocytes and CD4182 LN cells were susceptible to apop-
tosis mediated by TCR ligation alone. This form of apop-
tosis was Fas dependent and was not seen after combined
TCR–CD28 ligation, implying that costimulation blocked
apoptosis. Likewise, TCR-mediated apoptosis of mature
T cells was not detectable after addition of small numbers
of spleen APC as a source of bystander costimulation (data
not shown). Since APC are found in all lymphoid organs,
including the thymus, the chances of mature T cells being
subjected to TCR ligation in vivo in the absence of co-
stimulation would seem unlikely. For this reason, we sug-
gest that the rapid onset of Fas-mediated apoptosis de-
scribed here for naive T cells after TCR ligation in vitro
may not operate under in vivo conditions.
It is important to emphasize that the rapid (,20 h) onset
of TCR-mediated apoptosis of mature naive T cells was
not associated with entry into cell cycle (although entry into
G1 has not been excluded) (data not shown). This finding
differs from activation-induced cell death (AICD), in which
apoptosis of mature T cells generally follows a prior prolif-
erative response (42). Nevertheless, it is striking that, as for
naive T cells, AICD is Fas dependent (36–38, 43); in addi-
tion, some groups (44, 45) but not others (43) find that co-
stimulation prevents AICD. Hence, AICD and the rapid
death of naive T cells described here may be closely related.
It should be stressed that demonstrating TCR-mediated apop-
tosis of naive T cells required (a) a high concentration of
anti-TCR mAb in cross-linked form, (b) a virtual absence
of APC, and (c) a highly sensitive technique (TUNEL) for
detecting apoptosis. These strict requirements may explain
why early TCR-mediated apoptosis of naive T cells is not
seen routinely by other groups.
For mature and semimature T cells, susceptibility to Fas-
dependent apoptosis following TCR ligation in the ab-
sence of costimulation correlated with rapid upregulation
of FasL (our unpublished data). Thus, apoptosis presumably
reflected Fas–FasL interaction. Interestingly, no upregula-
tion of FasL was seen when purified CD4181 cells were
exposed to either TCR or TCR–CD28 ligation. Hence,
the failure to detect a role for Fas in apoptosis of CD4181
cells (Fig. 4) could simply reflect that, despite their high den-
sity of Fas, CD4181 cells are unable to upregulate FasL. It
should be mentioned that exposing CD4181 cells to cross-
linked anti-Fas mAb causes rapid apoptosis (our unpub-
lished data), indicating that the Fas death pathway is intact
in CD4181 cells.
The capacity of costimulation to prevent TCR-mediated
apoptosis was unique to mature T cells and did not apply to
CD4181 or HSAhi CD4182 thymocytes. For these popula-
tions, the presence of costimulation was either essential for
TCR-mediated apoptosis (for CD4181 cells) or consider-
ably enhanced apoptosis (for HSAhi CD4182 cells). How co-
stimulation alters the susceptibility of thymocyte subsets to
TCR-mediated apoptosis is unclear. For fully mature HSAlo
CD4182 thymocytes and LN cells, preliminary data has
shown that combined TCR–CD28 ligation causes strong
upregulation of Bcl-xL (our unpublished data); this finding
is not seen with TCR ligation alone. Thus, for mature T cells,
the capacity of costimulation to prevent TCR-mediated
apoptosis could be attributed to rapid upregulation of anti-
apoptotic molecules such as Bcl-xL (44). Interestingly, in
the case of semimature HSAhi CD4182 thymocytes, we
have found that upregulation of Bcl-xL following TCR–
CD28 ligation is minimal. Hence, the inability of costimu-
lation to prevent apoptosis of semimature T cells may re-
flect a failure of these cells to upregulate Bcl-xL.
Because a requirement for costimulation is an important
feature of negative selection in the thymus, the susceptibil-
ity of thymocytes to TCR–CD28-mediated apoptosis in
vitro would seem to be a valid model for defining which
subsets of thymocytes are subject to negative selection in
vivo. With this assumption, the present data suggest that
negative selection is not restricted to immature cortical
CD4181 cells but also includes the semimature population
of HSAhi CD4182 cells found in the medulla. In support of
this view, each of these populations was eliminated after in-
jection of anti-TCR mAb in vivo; under these conditions,
costimulation was presumably presented in bystander form
by thymic APC. It is notable that anti-TCR injection
failed to destroy HSAlo CD4182 thymocytes. This finding
is in agreement with the current dogma that fully mature
T cells are resistant to negative selection.
The finding that negative selection includes the semima-
ture subset of HSAhi CD4182 cells found in the medulla
provides direct support for the view that the medulla is an
important site of negative selection. Thus, one can envisage269 Kishimoto and Sprent
that purging the T cell repertoire of reactivity to circulating
self-antigens may occur at a relatively late stage of T cell
differentiation and be delayed until semimature CD4182
cells reach the APC-enriched environment of the medulla
and cortico–medullary junction. After being screened for
self-reactivity in these sites, the surviving T cells then dif-
ferentiate into fully mature T cells and are exported to the
periphery. It is of interest that, under in vitro conditions,
HSAhi CD4182 cells were significantly (5-fold) less sensi-
tive to TCR–CD28-mediated apoptosis than immature
CD4181 cells. While having only minimal effects on the
efficiency of negative selection, this mild reduction in tol-
erance susceptibility could be vital for enabling SP cells to
be refractory to weak (antagonist or partial agonist) self-
peptides on APC, i.e., to the ubiquitous self-peptides that
initially signaled positive selection in the cortex at the DP
stage (7, 46). This notion would explain why the reactivity of
early thymocytes for the weak peptides controlling positive
selection is apparently lost when the cells begin to mature
and move from the cortex to the medulla (47).
The signaling pathways involved in negative selection of
medullary HSAhi CD4182 cells remain to be clarified. Be-
cause the density and TCR–MHC affinity of each self-
antigen expressed on medullary APC is likely to vary con-
siderably, efficient negative selection of HSAhi CD4182 cells
could depend upon multiple signaling pathways, the in-
volvement of each pathway being determined by the rela-
tive strength and density of the self-antigen concerned. In
this respect, it is notable that a Fas-independent pathway con-
trolled TCR–CD28-mediated apoptosis of HSAhi CD4182
cells in vitro, but only at a low dose of anti-TCR mAb. At
higher doses, the Fas-independent pathway failed, and neg-
ative selection required a secondary mechanism, i.e., a Fas-
mediated pathway. This finding raises the possibility that
negative selection in Fas-deficient lpr/lpr mice would not
occur if the concentration of antigen were raised to a high
level. In fact, recent studies with soluble superantigens have
shown that this is indeed the case (our unpublished data).
The participation of multiple signaling pathways in nega-
tive selection could explain the difficulty of defining which
particular costimulatory molecules are required for this
process. Thus, despite the in vitro results reported here, co-
stimulation via CD28–B7 interaction apparently is not
mandatory for negative selection in vivo (9, 48, 49). How-
ever, it does not necessarily follow that this pathway is un-
important. Bearing in mind the large variety of costimula-
tory molecules on APC, many or all of these molecules
could provide effective costimulation for negative selection
under in vivo conditions. If so, the consequences of delet-
ing only one of these molecules, e.g., B7 (or CD28) or Fas,
would then be relatively minor. The participation of multi-
ple signaling pathways and various costimulatory molecules
in negative selection could represent a fail-safe device to en-
sure that self-tolerance induction is as efficient as possible.
Irrespective of which particular signaling pathways are
involved in negative selection, the main finding in this pa-
per is that the tolerance susceptibility of thymocytes is not
restricted to immature cortical CD4181 cells, but includes
the semimature subset of HSAhi CD4182 cells found in the
medulla. Thus, the data support the view that negative se-
lection to circulating self-antigens occurs at a relatively late
stage of thymocyte differentiation, i.e., after the differentia-
tion of DP cells to SP cells and after migration of early SP
cells into the medulla.
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